Sbarro Health Research Organization, on the occasion of the medical conference “The impact of environment and healthy lifestyles in human health,” honoured Nathalie Dompé, CEO Dompé Holdings, with a special Award for Societal Impact in Business & Biotechnology, for her work and effort in promoting social responsibility.
Researchers have demonstrated an integrated technique for monitoring specific biomolecules – such as growth factors – that could indicate the health of living cell cultures produced for the burgeoning field of cell-based therapeutics.
XLerateHealth, LLC, a Louisville-based healthcare technology accelerator that focuses on startups and commercialization, will join forces with a consortium of 24 academic institutions led by the University of Kentucky (UK), in partnership with the University of Louisville (UofL) and West Virginia University (WVU).
Two summers ago, biomedical engineering students at Rutgers University–New Brunswick immersed themselves at Matheny in Peapack, New Jersey, a nonprofit organization that is home to scores of children and adults with cerebral palsy, spina bifida and other developmental disabilities. The students’ goal: find ways to improve their independence and quality of life. After talking with staffers and students at Matheny, the Rutgers students designed prototypes that were demonstrated there last spring. The reaction was very positive.
Northwestern University and Washington University School of Medicine researchers have developed the first example of a bioelectronic medicine: an implantable, biodegradable wireless device that speeds nerve regeneration and improves healing of a damaged nerve. Their device delivered pulses of electricity to damaged nerves in rats after a surgical repair process, accelerating the regrowth of nerves and enhancing the recovery of muscle strength and control. The device is the size of a dime and the thickness of a sheet of paper.
A new method for sequencing the chemical groups attached to the surface of DNA is paving the way for better detection of cancer and other diseases in the blood.
The medical conference is organized by the Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano Foundation
Foundation Awards Presented for Ethics and Creativity in Medical Research, and Societal Impact in Business & Biotechnology
UD engineers will be looking at using how a group of bacteria, usually associated with causing stomach troubles, could be used to create sources of sustainable energy.
MSU scientists have a new proof of concept for a biofuel production platform that uses two species of marine algae and soil fungi. It lowers cultivation and harvesting costs and increases productivity, factors that currently hold back biofuels from being widely adopted.
New 3D maps of water distribution during cellular membrane fusion could lead to new treatments for diseases associated with cell fusion. Using neutron diffraction at Oak Ridge National Laboratory, scientists made the first direct observations of water in lipid bilayers modeling cell membrane fusion.
Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids. The newly published research in the journal Cell Stem Cell is the first time scientists have been able to grow human esophageal tissue entirely from pluripotent stem cells (PSCs), which can form any tissue type in the body.
MyoKardia, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today announced the launch of the MyoSeeds™ Research Grants Program, a new initiative to support original, independent research in the biology and underlying mechanisms of cardiomyopathies and precision heart disease treatment with the goal of improving the lives of patients.
A three-year, $1.8 million grant from the National Institutes of Health will enable researchers at the University of Illinois at Chicago to develop portable, easy-to-use sensors that can detect toxic metals in a single drop of blood. The sensors would allow for faster and cheaper research, as well as rapid detection of metals including manganese and lead, both of which are powerful neurotoxins that can affect cognitive development and neuromotor function.
A new wearable ultrasound patch that non-invasively monitors blood pressure in arteries deep beneath the skin could help people detect cardiovascular problems earlier on and with greater precision. In tests, the patch performed as well as some clinical methods to measure blood pressure. Applications include real-time, continuous monitoring of blood pressure changes in patients with heart or lung disease, as well as patients who are critically ill or undergoing surgery.
Findings may yield new closed-loop, tailored therapies for depression and anxiety
National Institutes of Health Director Francis S. Collins, M.D., Ph.D., has selected Bruce J. Tromberg, Ph.D., as director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). A pioneering leader in the field of biophotonics, Dr. Tromberg is currently a professor at the University of California at Irvine.
Six years in the making, the U.S. Department of Energy’s (DOE) Knowledgebase (KBase) program offers the most updated system for recording experimental methods
Projects focused on providing simple, low-cost modifications to surgical techniques that could reduce pain or damage from these procedures dominated this year’s Design by Biomedical Undergraduate Teams (DEBUT) challenge.
It may seem that there isn't much cross-discussion between theoretical and empirical scientists, but a new cross-citation network analysis shows there is more overlap than many believe.
As part of a new study, researchers at the University of Notre Dame aim to create a more optimal computer network for solving complex problems — using heart cells.
he use of mud or wet clay as a topical skin treatment or a poultice is a common practice in some cultures and the concept of using mud as medicine goes back to earliest times. Now Mayo Clinic researchers and their collaborators at Arizona State University have found that at least one type of clay may help fight disease-causing bacteria in wounds, including some treatment-resistant bacteria. The findings appear in the International Journal of Antimicrobial Agents.
Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.
Stacey S. Kelpke, Ph.D., an experienced biomedical/bioengineering researcher, has been named program manager of Southern Research's medical device technologies initiative, AIMTech.
Systems biology leads the way to exascale computing on Summit supercomputer.
Scientists at the Innovative Genomics Institute have concocted a transformative new way to harness the power of evolution. Today in Nature, researchers at UC Berkeley describe yet another creative application for CRISPR: a platform to spur evolution of specific genes inside cells. Their inventive new system, “EvolvR,” lets scientists shake up the DNA letters in their gene of choice until they find the variation that’s just right. The technology opens up countless possibilities, like engineering yeast that efficiently turn waste into biofuels, or developing new human therapeutics.
Increasing healthy brown fat might help weight management and reduce symptoms of diabetes. Columbia Engineers have developed a simple, innovative method to directly convert white fat to brown fat outside the body and then reimplant it in a patient. The technique uses fat-grafting procedures commonly performed by plastic surgeons, in which fat is harvested from under the skin and then retransplanted into the same patient for cosmetic or reconstructive purposes.
The research shows that a freshwater production strain of microalgae, Auxenochlorella protothecoides, is capable of directly degrading and utilizing non-food plant substrates, such as switchgrass, for improved cell growth and lipid productivity, useful for boosting the algae’s potential value as a biofuel.
Beginning in the fall of 2018, Clarkson University will offer a new master’s degree program in Interdisciplinary Bioscience & Biotechnology (IBB-MS).
A “smart” bandage is designed to monitor the condition of chronic wounds and deliver drug treatments to improve chances of healing. While the bandages remain to be assessed in a clinical context, the research is aimed at transforming bandaging from a passive to an active treatment paradigm.
A technology developed at Israel's Technion will provide the scientific community with novel tools to gain a comprehensive understanding of immune system activity. Based on millions of scientific publications, the technology uses artificial intelligence to map disease immune profiles. These maps, which have already identified previously unknown biological interactions, will enable development of personalized, immuno-centric therapies
Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized ‘miniecosystems’ to quickly see if a molecule can function as a potential therapeutic.
A new study by Scripps Research, published today in Nature Communications, suggests scientists could build better drugs by learning from bacteria-derived molecules called thiocarboxylic acids.
With this latest grant, FAU will establish a primary care workforce of students with a bachelor of science in nursing degree who are practice ready and willing to serve veterans and patients in rural and underserved communities.
Rutgers researchers have created an automated blood drawing and testing device that provides rapid results, potentially improving the workflow in hospitals and other health-related institutions to allow health care practitioners to spend more time treating patients. A study describing the fully automated device is published online in the journal TECHNOLOGY.
Scientists, biotech, engineering and commercial building and design professionals are gathering at the Life Sciences Real Estate Development Symposium today to reimagine New York City using biology, and to thoughtfully begin planning for building new environments to accommodate projected rapid expansion of applied life sciences in the City and globally. The newly forming NYC Builds Bio+ initiative, an interdisciplinary collaborative organization of leaders in real estate and life sciences, will be announced at the meeting in response to the projected unprecedented decade of growth ahead.
Stony Brook University ‘s Center for Biotechnology (CFB) has been selected as one of eight U.S. Department of Health and Human Services (HHS) BARDA-DRIVe accelerators. Each of these accelerators is directed to support bioscience companies to develop health security innovations within the national ecosystem.
By altering the genetic code in bacteria, researchers at The University of Texas at Austin have demonstrated a method to make therapeutic proteins more stable, an advance that would improve the drugs' effectiveness and convenience
The latest research and features in cell biology in the Cell Biology News Source
Columbia Engineers have developed a non-invasive approach to permanently correct vision that shows great promise in preclinical models. The method uses a femtosecond oscillator for selective and localized alteration of the biochemical and biomechanical properties of corneal tissue. The technique, which changes the tissue’s macroscopic geometry, is non-surgical and has fewer side effects and limitations than those seen in refractive surgeries. The study could lead to treatment for myopia, hyperopia, astigmatism, and irregular astigmatism.
The latest research, features, and experts on HIV and AIDS.
ThyroSeq® announced today that it will present performance data on utilization of ThyroSeq v3 Genomic Classifier at the upcoming American Association of Clinical Endocrinologists (AACE) 27th Annual Scientific & Clinical Congress.
Click here to go directly to the Cancer News Source
Beta peptides have become a key tool in building more robust biomaterials. These synthetic molecules mimic the structure of small proteins, but they are protected against processes that degrade natural peptides. A new study has expanded what we can do with these crafty peptides. Published in APL Bioengineering, the researchers show that molecules that have previously posed challenges to bioengineers can now be used to make new kinds of biomaterials.
The Center for Excellence in Engineering Biology and the leadership of Genome Project-write (GP-write) today announced its first grand-scale community-wide project, to develop “ultra-safe cells” that resist natural viruses and potentially radiation, freezing, aging and cancer.
Melanoma, a relatively rare but deadly skin cancer, has been shown to switch differentiation states, which can lead it to become resistant to treatment. Now, UCLA researchers have found that melanomas can be divided into four distinct subtypes according to their stages of differentiation.
Imagine if all childhood vaccines could get delivered with an inhaler rather than shots; or wiping away tuberculosis bacteria in a patient’s lungs with an inhaler; or disinfecting a hospital room thoroughly with a diffuser. These are the goals of a research team led by Professor James Friend in the Department of Mechanical and Aerospace Engineering at the University of California San Diego. Their efforts were recently boosted when Friend received a prestigious $900,000 research grant from the Keck Foundation, whose mission is to support pioneering discoveries in science, engineering and medical research.
UCLA researchers have tweaked CRISPR technology, enabling them to monitor the outcome of tens of thousands of gene edits in the time it currently takes to analyze a few. The advance will improve scientists’ ability to identify the genetic changes most likely to harm cells and contribute to disease.
Researchers at The Johns Hopkins Kimmel Cancer Center have developed a test for urine, gathered during a routine procedure, to detect DNA mutations identified with urothelial cancers.
A promising discovery for advanced cancer therapy reveals that the efficiency of drug delivery in DNA nanostructures depends on their shapes, say researchers at Missouri University of Science and Technology and the University of Kansas in a scientific paper published today (March 21, 2018).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right